These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3899047)

  • 1. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.
    Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Ismond D
    Arch Gen Psychiatry; 1985 Oct; 42(10):962-6. PubMed ID: 3899047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hyperactive children with monoamine oxidase inhibitors. II. Plasma and urinary monoamine findings after treatment.
    Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Karoum F; Potter WZ; Ismond D
    Arch Gen Psychiatry; 1985 Oct; 42(10):969-73. PubMed ID: 2412521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.
    Feinberg SS
    J Clin Psychiatry; 2004 Nov; 65(11):1520-4. PubMed ID: 15554766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drug trials in attention deficit disorder.
    Rapoport JL; Zametkin A; Donnelly M; Ismond D
    Psychopharmacol Bull; 1985; 21(2):232-6. PubMed ID: 3923528
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bupropion treatment of attention-deficit hyperactivity disorder in adults.
    Wender PH; Reimherr FW
    Am J Psychiatry; 1990 Aug; 147(8):1018-20. PubMed ID: 2115746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity.
    Shekim WO; Bylund DB; Alexson J; Glaser RD; Jones SB; Hodges K; Perdue S
    Psychiatry Res; 1986 Jun; 18(2):179-88. PubMed ID: 3725999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug treatment for hyperactive children. Therapeutic guidelines.
    Elia J
    Drugs; 1993 Nov; 46(5):863-71. PubMed ID: 7507036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naturalistic assessment of the motor activity of hyperactive boys. II. Stimulant drug effects.
    Porrino LJ; Rapoport JL; Behar D; Ismond DR; Bunney WE
    Arch Gen Psychiatry; 1983 Jun; 40(6):688-93. PubMed ID: 6847336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cardiovascular response to monoamine oxidase inhibitors: a prospective assessment.
    Keck PE; Vuckovic A; Pope HG; Nierenberg AA; Gribble GW; White K
    J Clin Psychopharmacol; 1989 Jun; 9(3):203-6. PubMed ID: 2738182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAOIs in the contemporary treatment of depression.
    Thase ME; Trivedi MH; Rush AJ
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranylcypromine isomers in depressed outpatients: effects on depression, monoamine oxidase inhibition and tyramine pressor response.
    Van de Merwe TJ; Pare CM; Glover V; Sandler M
    Mod Probl Pharmacopsychiatry; 1983; 19():189-202. PubMed ID: 6346066
    [No Abstract]   [Full Text] [Related]  

  • 18. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
    Donnelly M; Rapoport JL; Potter WZ; Oliver J; Keysor CS; Murphy DL
    Arch Gen Psychiatry; 1989 Mar; 46(3):205-12. PubMed ID: 2645848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAO inhibitors in mental disease: their current status.
    Dowson JH
    J Neural Transm Suppl; 1987; 23():121-38. PubMed ID: 3295114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
    Fawcett J; Kravitz HM; Zajecka JM; Schaff MR
    J Clin Psychopharmacol; 1991 Apr; 11(2):127-32. PubMed ID: 2056139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.